Literature DB >> 18843048

Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.

Zendra Lee1, Ching-Ting Cheng, Helen Zhang, Mark A Subler, Jinhua Wu, Abir Mukherjee, Jolene J Windle, Ching-Kang Chen, Xianjun Fang.   

Abstract

Lysophosphatidic acid (LPA) is a ligand of multiple G protein-coupled receptors. The LPA(1-3) receptors are members of the endothelial cell differentiation gene (Edg) family. LPA(4)/p2y9/GPR23, a member of the purinergic receptor family, and recently identified LPA(5)/GPR92 and p2y5 are structurally distant from the canonical Edg LPA receptors. Here we report targeted disruption of lpa(4) in mice. Although LPA(4)-deficient mice displayed no apparent abnormalities, LPA(4)-deficient mouse embryonic fibroblasts (MEFs) were hypersensitive to LPA-induced cell migration. Consistent with negative modulation of the phosphatidylinositol 3 kinase pathway by LPA(4), LPA(4) deficiency potentiated Akt and Rac but decreased Rho activation induced by LPA. Reconstitution of LPA(4) converted LPA(4)-negative cells into a less motile phenotype. In support of the biological relevance of these observations, ectopic expression of LPA(4) strongly inhibited migration and invasion of human cancer cells. When coexpressed with LPA(1) in B103 neuroblastoma cells devoid of endogenous LPA receptors, LPA(4) attenuated LPA(1)-driven migration and invasion, indicating functional antagonism between the two subtypes of LPA receptors. These results provide genetic and biochemical evidence that LPA(4) is a suppressor of LPA-dependent cell migration and invasion in contrast to the motility-stimulating Edg LPA receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843048      PMCID: PMC2592656          DOI: 10.1091/mbc.e08-03-0316

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  45 in total

1.  Determination of GTP loading on Rho.

Authors:  X D Ren; M A Schwartz
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3.

Authors:  I Ishii; B Friedman; X Ye; S Kawamura; C McGiffert; J J Contos; M A Kingsbury; G Zhang; J H Brown; J Chun
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

3.  Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.

Authors:  I Ishii; J J Contos; N Fukushima; J Chun
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

4.  Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.

Authors:  D S Im; C E Heise; M A Harding; S R George; B F O'Dowd; D Theodorescu; K R Lynch
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

5.  Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.

Authors:  Takamitsu Sano; Daniel Baker; Tamas Virag; Atsushi Wada; Yutaka Yatomi; Tetsuyuki Kobayashi; Yasuyuki Igarashi; Gabor Tigyi
Journal:  J Biol Chem       Date:  2002-04-02       Impact factor: 5.157

6.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 7.  Regulation and biological activities of the autotaxin-LPA axis.

Authors:  Laurens A van Meeteren; Wouter H Moolenaar
Journal:  Prog Lipid Res       Date:  2007-03-16       Impact factor: 16.195

8.  LPA1 receptor activation promotes renal interstitial fibrosis.

Authors:  Jean-Philippe Pradère; Julie Klein; Sandra Grès; Charlotte Guigné; Eric Neau; Philippe Valet; Denis Calise; Jerold Chun; Jean-Loup Bascands; Jean-Sébastien Saulnier-Blache; Joost P Schanstra
Journal:  J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 10.121

9.  The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.

Authors:  Andrew M Tager; Peter LaCamera; Barry S Shea; Gabriele S Campanella; Moisés Selman; Zhenwen Zhao; Vasiliy Polosukhin; John Wain; Banu A Karimi-Shah; Nancy D Kim; William K Hart; Annie Pardo; Timothy S Blackwell; Yan Xu; Jerold Chun; Andrew D Luster
Journal:  Nat Med       Date:  2007-12-09       Impact factor: 53.440

10.  Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.

Authors:  Regina A Oyesanya; Zendra P Lee; Jinhua Wu; Jing Chen; Yuanda Song; Abir Mukherjee; Paul Dent; Tomasz Kordula; Huiping Zhou; Xianjun Fang
Journal:  FASEB J       Date:  2008-03-24       Impact factor: 5.191

View more
  60 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.

Authors:  Sue-Chin Lee; Yuko Fujiwara; Jianxiong Liu; Junming Yue; Yoshibumi Shimizu; Derek D Norman; Yaohong Wang; Ryoko Tsukahara; Erzsebet Szabo; Renukadevi Patil; Souvik Banerjee; Duane D Miller; Louisa Balazs; Manik C Ghosh; Christopher M Waters; Tamas Oravecz; Gabor J Tigyi
Journal:  Mol Cancer Res       Date:  2014-08-26       Impact factor: 5.852

Review 5.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

6.  Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.

Authors:  Guo Li; Philip D Mosier; Xianjun Fang; Yan Zhang
Journal:  J Mol Graph Model       Date:  2009-04-19       Impact factor: 2.518

Review 7.  Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.

Authors:  Xiaoqin Ye; Jerold Chun
Journal:  Trends Endocrinol Metab       Date:  2010-01       Impact factor: 12.015

8.  Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.

Authors:  Molly K Altman; Vashisht Gopal; Wei Jia; Shuangxing Yu; Hassan Hall; Gordon B Mills; A Cary McGinnis; Michael G Bartlett; Guowei Jiang; Damian Madan; Glenn D Prestwich; Yong Xu; Michael A Davies; Mandi M Murph
Journal:  Mol Cancer       Date:  2010-06-09       Impact factor: 27.401

Review 9.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

10.  Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid.

Authors:  Regina A Oyesanya; Susie Greenbaum; David Dang; Zendra Lee; Abir Mukherjee; Jinhua Wu; Paul Dent; Xianjun Fang
Journal:  Mol Cancer       Date:  2010-01-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.